These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 18358048)
21. UDP-galactopyranose mutase has a novel structure and mechanism. Sanders DA; Staines AG; McMahon SA; McNeil MR; Whitfield C; Naismith JH Nat Struct Biol; 2001 Oct; 8(10):858-63. PubMed ID: 11573090 [TBL] [Abstract][Full Text] [Related]
22. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors. Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902 [TBL] [Abstract][Full Text] [Related]
23. Structural basis of ligand binding to UDP-galactopyranose mutase from Mycobacterium tuberculosis using substrate and tetrafluorinated substrate analogues. van Straaten KE; Kuttiyatveetil JR; Sevrain CM; Villaume SA; Jiménez-Barbero J; Linclau B; Vincent SP; Sanders DA J Am Chem Soc; 2015 Jan; 137(3):1230-44. PubMed ID: 25562380 [TBL] [Abstract][Full Text] [Related]
24. Potent ligands for prokaryotic UDP-galactopyranose mutase that exploit an enzyme subsite. Dykhuizen EC; Kiessling LL Org Lett; 2009 Jan; 11(1):193-6. PubMed ID: 19067595 [TBL] [Abstract][Full Text] [Related]
25. The UDP-Galp mutase catalyzed isomerization: synthesis and evaluation of 1,4-anhydro-beta-D-galactopyranose and its [2.2.2] methylene homologue. Sadeghi-Khomami A; Forcada TJ; Wilson C; Sanders DA; Thomas NR Org Biomol Chem; 2010 Apr; 8(7):1596-602. PubMed ID: 20237670 [TBL] [Abstract][Full Text] [Related]
26. A new methodology for the synthesis of fluorinated exo-glycals and their time-dependent inhibition of UDP-galactopyranose mutase. Caravano A; Dohi H; Sinaÿ P; Vincent SP Chemistry; 2006 Apr; 12(11):3114-23. PubMed ID: 16429471 [TBL] [Abstract][Full Text] [Related]
27. Identification of inhibitors for UDP-galactopyranose mutase. Soltero-Higgin M; Carlson EE; Phillips JH; Kiessling LL J Am Chem Soc; 2004 Sep; 126(34):10532-3. PubMed ID: 15327298 [TBL] [Abstract][Full Text] [Related]
28. Investigation of binding of UDP-Galf and UDP-[3-F]Galf to UDP-galactopyranose mutase by STD-NMR spectroscopy, molecular dynamics, and CORCEMA-ST calculations. Yuan Y; Bleile DW; Wen X; Sanders DA; Itoh K; Liu HW; Pinto BM J Am Chem Soc; 2008 Mar; 130(10):3157-68. PubMed ID: 18278916 [TBL] [Abstract][Full Text] [Related]
29. Identification of Novel Inhibitors of UDP-Galactopyranose Mutase by Structure-Based Virtual Screening. Karunan Partha S; Sadeghi-Khomami A; Cren S; Robinson RI; Woodward S; Slowski K; Berast L; Zheng B; Thomas NR; Sanders DA Mol Inform; 2011 Oct; 30(10):873-83. PubMed ID: 27468107 [TBL] [Abstract][Full Text] [Related]
30. Synthesis of thiohydantoin-castanospermine glycomimetics as glycosidase inhibitors. Aguilar-Moncayo M; Mellet CO; García Fernández JM; García-Moreno MI J Org Chem; 2009 May; 74(9):3595-8. PubMed ID: 19334717 [TBL] [Abstract][Full Text] [Related]
31. Reversible and efficient inhibition of UDP-galactopyranose mutase by electrophilic, constrained and unsaturated UDP-galactitol analogues. Ansiaux C; N'Go I; Vincent SP Chemistry; 2012 Nov; 18(46):14860-6. PubMed ID: 23015271 [TBL] [Abstract][Full Text] [Related]
32. Synthetic UDP-furanoses as potent inhibitors of mycobacterial galactan biogenesis. Peltier P; Beláňová M; Dianišková P; Zhou R; Zheng RB; Pearcey JA; Joe M; Brennan PJ; Nugier-Chauvin C; Ferrières V; Lowary TL; Daniellou R; Mikušová K Chem Biol; 2010 Dec; 17(12):1356-66. PubMed ID: 21168771 [TBL] [Abstract][Full Text] [Related]
33. Tautomerization in the UDP-galactopyranose mutase mechanism: a DFT-cluster and QM/MM investigation. Huang W; Gauld JW J Phys Chem B; 2012 Dec; 116(48):14040-50. PubMed ID: 23148701 [TBL] [Abstract][Full Text] [Related]
37. Substrate directs enzyme dynamics by bridging distal sites: UDP-galactopyranose mutase. Yao X; Bleile DW; Yuan Y; Chao J; Sarathy KP; Sanders DA; Pinto BM; O'Neill MA Proteins; 2009 Mar; 74(4):972-9. PubMed ID: 18767162 [TBL] [Abstract][Full Text] [Related]
38. Tetrafluorination of sugars as strategy for enhancing protein-carbohydrate affinity: application to UDP-Galp mutase inhibition. N'Go I; Golten S; Ardá A; Cañada J; Jiménez-Barbero J; Linclau B; Vincent SP Chemistry; 2014 Jan; 20(1):106-12. PubMed ID: 24311368 [TBL] [Abstract][Full Text] [Related]
39. Identification of eukaryotic UDP-galactopyranose mutase inhibitors using the ThermoFAD assay. Martín Del Campo JS; Eckshtain-Levi M; Sobrado P Biochem Biophys Res Commun; 2017 Nov; 493(1):58-63. PubMed ID: 28919416 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and Evaluation of Bicyclo[3.1.0]hexane-Based UDP-Galf Analogues as Inhibitors of the Mycobacterial Galactofuranosyltransferase GlfT2. Lowary TL; Li J Molecules; 2016 Aug; 21(8):. PubMed ID: 27529206 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]